JPWO2024014524A1 - - Google Patents
Info
- Publication number
- JPWO2024014524A1 JPWO2024014524A1 JP2024533757A JP2024533757A JPWO2024014524A1 JP WO2024014524 A1 JPWO2024014524 A1 JP WO2024014524A1 JP 2024533757 A JP2024533757 A JP 2024533757A JP 2024533757 A JP2024533757 A JP 2024533757A JP WO2024014524 A1 JPWO2024014524 A1 JP WO2024014524A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022113930 | 2022-07-15 | ||
| PCT/JP2023/025980 WO2024014524A1 (ja) | 2022-07-15 | 2023-07-14 | 血中ｌｄｌコレステロール低下剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024014524A1 true JPWO2024014524A1 (https=) | 2024-01-18 |
Family
ID=89536850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533757A Pending JPWO2024014524A1 (https=) | 2022-07-15 | 2023-07-14 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20260014122A1 (https=) |
| EP (1) | EP4556006A4 (https=) |
| JP (1) | JPWO2024014524A1 (https=) |
| KR (1) | KR20250034041A (https=) |
| CN (1) | CN119546300A (https=) |
| JO (1) | JOP20250007A1 (https=) |
| TW (1) | TW202408500A (https=) |
| WO (1) | WO2024014524A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA009374B1 (ru) | 2003-09-03 | 2007-12-28 | Кова Ко., Лтд. | Активирующее ppar соединение и содержащая его фармацевтическая композиция |
| TWI696462B (zh) * | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
| DK3275438T3 (da) * | 2016-07-29 | 2021-01-18 | Kowa Co | Fremgangsmåder til forebyggelse af hjerte-kar-hændelser hos dyslipidæmiske populationer med fortsat risiko |
| JP2021506907A (ja) * | 2017-12-21 | 2021-02-22 | 興和株式会社 | 高トリグリセライド血症の治療方法 |
| US11446282B2 (en) * | 2017-12-21 | 2022-09-20 | Kowa Company, Ltd. | Methods of treating mixed dyslipidemia and hypertriglycertdemia |
| US20240277745A1 (en) * | 2021-05-27 | 2024-08-22 | Kowa Company, Ltd | Pemafibrate and/or tofogliflozin for use in treating liver disease |
-
2023
- 2023-07-14 EP EP23839693.1A patent/EP4556006A4/en active Pending
- 2023-07-14 WO PCT/JP2023/025980 patent/WO2024014524A1/ja not_active Ceased
- 2023-07-14 CN CN202380054016.8A patent/CN119546300A/zh active Pending
- 2023-07-14 US US18/880,136 patent/US20260014122A1/en active Pending
- 2023-07-14 KR KR1020247043248A patent/KR20250034041A/ko active Pending
- 2023-07-14 JP JP2024533757A patent/JPWO2024014524A1/ja active Pending
- 2023-07-14 TW TW112126331A patent/TW202408500A/zh unknown
-
2025
- 2025-01-13 JO JOJO/P/2025/0007A patent/JOP20250007A1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024014524A1 (ja) | 2024-01-18 |
| KR20250034041A (ko) | 2025-03-10 |
| JOP20250007A1 (ar) | 2025-01-13 |
| EP4556006A4 (en) | 2026-01-07 |
| CN119546300A (zh) | 2025-02-28 |
| TW202408500A (zh) | 2024-03-01 |
| EP4556006A1 (en) | 2025-05-21 |
| US20260014122A1 (en) | 2026-01-15 |